blog

Small to Mid-Size Pharmaceutical Companies Are Meeting the Needs of a Shifting Marketplace

By Joan F. Bachenheimer on Tue, Jun 4, 2019 | 2 min read

Last year, smaller companies led in new drug approvals, according to a recent OutsourcingPharma.com article featuring Ken Getz, director of sponsored research at Tufts University. Notably, nearly half of these new drugs were for the treatment of rare diseases, demonstrating a shift within the industry away from a focus on scaling infrastructure.*

Scaling-down-Clinical-research-shifts-its-focus_wrbm_large

CEO and Founding Principal of BBK Worldwide, Joan F. Bachenheimer, responds to the article, explaining that “the precision aspects of clinical trial discovery have remapped the patient experience. The more targeted the investigational therapy, the more individualized the orientation becomes toward patient recruitment and engagement. It’s logical that the search for patients with specific biomarkers begets an orientation centered on individual needs versus a mass orientation."

Topics: Trends, Clinical Research, Rare Disease Research, Patient Experience, Precision Medicine

Guest Spotlight: Improving Patient Engagement

By BBK on Thu, May 5, 2016 | 3 min read

For this week’s Guest Blog Spotlight and in recognition of Clinical Trials Awareness Week, we’re sharing insights on improving patient engagement from Rare Genomics Institute and Rareshare.org, and contributors to our recent Rare Disease eBook. We asked Rare Genomics CEO Paul Schindler, Director of Strategic Alliances Nolin Huddleston, and Rareshare.org’s Head of Operations and Development Alice Cheng, “How can sponsors take a more active role in building and supporting rare disease communities?”

Topics: Patient Engagement, eBook, Rare Disease, Rare Disease Research

Guest Spotlight: Genetics and Discovery in Rare Disease Research

By BBK on Fri, Apr 29, 2016 | 2 min read

“We know today that we can define the root cause of genetic diseases. We have a growing toolkit with which to we can aggressively tackle and modify the underlying defect, which ultimately I believe will lead to benefits for the patients, improving their quality of life, and potentially for some, it may lead to cures.”

Topics: eBook, Rare Disease, Rare Disease Research

Guest Spotlight: Appreciating Every Patient’s Experience

By BBK on Tue, Apr 26, 2016 | 2 min read

“When so many rare disease patients commit themselves to becoming experts of their condition, sponsors must also strive to understand and collaborate with the patients they wish to engage.”


Topics: eBook, Rare Disease, Rare Disease Research

New eBook: Industry Insights on Rare Disease Research

By BBK on Tue, Apr 12, 2016 | 1 min read



Our “Focus 5” eBook series, in which we share the insights of five thought leaders on a variety of industry topics and trends, has been incredibly well-received, and we’re pleased to issue the latest installment in the series on Rare Disease Research. Patient advocates, researchers and physicians from NORD, Xenon Pharmaceuticals, Landon Pediatric Foundation, Rare Genomics Institute and RareShare.org all weigh in on where we are today and what we can do to help advance research.

Topics: Patient Centricity, Rare Disease, Clinical Trials, Rare Disease Research

 
Subscribe To Our Blog